Shire Investments & Fund Profile

Overview

Global biotechnology company focused on rare diseases and innovative therap

Founded

1986

Deals · 12mo

0

Links

Website LinkedIn

Stage focus

Multi-stage

Geographic focus

Belgium

France

The Netherlands

United States

Sector focus

Biopharma

Biotechnology

Genetics

Health Care

...

Investment portfolio

13rounds

LedParticipated

NAME	DATE	SIZE
Rani Therapeutics	Feb 2018Participated	$53 MOther Equity
Promethera Biosciences	Nov 2014Participated	$25 MSeries C
Proclara Biosciences	May 2013Participated	$6 MOther Equity
Naurex	Dec 2012Participated	$38 MSeries B
ArmaGen Technologies	Dec 2012Participated	$17 MSeries A
Bluebird Bio	Jul 2012Participated	$60 MSeries D
Promethera Biosciences	Mar 2012Participated	$31 MSeries B
Proclara Biosciences	Mar 2012Participated	$9 MSeries B
AM Pharma	Sep 2011Participated	$40 MSeries D
Prexa Pharmaceuticals	May 2011Participated	$7 MSeries B
Naurex	May 2011Participated	$18 MSeries A
Proclara Biosciences	Mar 2011Participated	$12 MSeries B
Rani Therapeutics	Feb 2018Participated	$53 MOther Equity
Promethera Biosciences	Nov 2014Participated	$25 MSeries C
Proclara Biosciences	May 2013Participated	$6 MOther Equity
Naurex	Dec 2012Participated	$38 MSeries B
ArmaGen Technologies	Dec 2012Participated	$17 MSeries A
Bluebird Bio	Jul 2012Participated	$60 MSeries D
Promethera Biosciences	Mar 2012Participated	$31 MSeries B
Proclara Biosciences	Mar 2012Participated	$9 MSeries B
AM Pharma	Sep 2011Participated	$40 MSeries D
Prexa Pharmaceuticals	May 2011Participated	$7 MSeries B
Naurex	May 2011Participated	$18 MSeries A
Proclara Biosciences	Mar 2011Participated	$12 MSeries B

13 Items

13

Items

...

Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Shire: 13 funding rounds are recorded in the selected participation categories. All available history
Round type	Led deals	Participated deals
Series A	0	2
Series B	0	5
Series C+	0	4
Other Equity	0	2

Monthly Deal Activity

Shire: 13 deals are recorded across 190 months. All available history
Month	Deals
Jan '11	1
Feb '11	0
Mar '11	1
Apr '11	0
May '11	2
Jun '11	0
Jul '11	0
Aug '11	0
Sep '11	1
Oct '11	0
Nov '11	0
Dec '11	0
Jan '12	0
Feb '12	0
Mar '12	2
Apr '12	0
May '12	0
Jun '12	0
Jul '12	1
Aug '12	0
Sep '12	0
Oct '12	0
Nov '12	0
Dec '12	2
Jan '13	0
Feb '13	0
Mar '13	0
Apr '13	0
May '13	1
Jun '13	0
Jul '13	0
Aug '13	0
Sep '13	0
Oct '13	0
Nov '13	0
Dec '13	0
Jan '14	0
Feb '14	0
Mar '14	0
Apr '14	0
May '14	0
Jun '14	0
Jul '14	0
Aug '14	0
Sep '14	0
Oct '14	0
Nov '14	1
Dec '14	0
Jan '15	0
Feb '15	0
Mar '15	0
Apr '15	0
May '15	0
Jun '15	0
Jul '15	0
Aug '15	0
Sep '15	0
Oct '15	0
Nov '15	0
Dec '15	0
Jan '16	0
Feb '16	0
Mar '16	0
Apr '16	0
May '16	0
Jun '16	0
Jul '16	0
Aug '16	0
Sep '16	0
Oct '16	0
Nov '16	0
Dec '16	0
Jan '17	0
Feb '17	0
Mar '17	0
Apr '17	0
May '17	0
Jun '17	0
Jul '17	0
Aug '17	0
Sep '17	0
Oct '17	0
Nov '17	0
Dec '17	0
Jan '18	0
Feb '18	1
Mar '18	0
Apr '18	0
May '18	0
Jun '18	0
Jul '18	0
Aug '18	0
Sep '18	0
Oct '18	0
Nov '18	0
Dec '18	0
Jan '19	0
Feb '19	0
Mar '19	0
Apr '19	0
May '19	0
Jun '19	0
Jul '19	0
Aug '19	0
Sep '19	0
Oct '19	0
Nov '19	0
Dec '19	0
Jan '20	0
Feb '20	0
Mar '20	0
Apr '20	0
May '20	0
Jun '20	0
Jul '20	0
Aug '20	0
Sep '20	0
Oct '20	0
Nov '20	0
Dec '20	0
Jan '21	0
Feb '21	0
Mar '21	0
Apr '21	0
May '21	0
Jun '21	0
Jul '21	0
Aug '21	0
Sep '21	0
Oct '21	0
Nov '21	0
Dec '21	0
Jan '22	0
Feb '22	0
Mar '22	0
Apr '22	0
May '22	0
Jun '22	0
Jul '22	0
Aug '22	0
Sep '22	0
Oct '22	0
Nov '22	0
Dec '22	0
Jan '23	0
Feb '23	0
Mar '23	0
Apr '23	0
May '23	0
Jun '23	0
Jul '23	0
Aug '23	0
Sep '23	0
Oct '23	0
Nov '23	0
Dec '23	0
Jan '24	0
Feb '24	0
Mar '24	0
Apr '24	0
May '24	0
Jun '24	0
Jul '24	0
Aug '24	0
Sep '24	0
Oct '24	0
Nov '24	0
Dec '24	0
Jan '25	0
Feb '25	0
Mar '25	0
Apr '25	0
May '25	0
Jun '25	0
Jul '25	0
Aug '25	0
Sep '25	0
Oct '25	0
Nov '25	0
Dec '25	0
Jan '26	0
Feb '26	0
Mar '26	0
Apr '26	0
May '26	0
Jun '26	0
Jul '26	0
Aug '26	0
Sep '26	0
Oct '26	0

Sector Breakdown

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Shire: Health & Life Sciences is the largest displayed sector by deal count (13 deals). All available history
Sector	Deals
Health & Life Sciences	13

Deal Size Distribution

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Shire: 13 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)	Deals
<$5M	0
$5M-$10M	3
$10M-$25M	3
$25M-$50M	5
$50M-$100M	2
$100M-$250M	0
$250M-$500M	0
$500M-$1B	0
$1B+	0

Deals By Geography

Top 2 of 2 regions; European countries are grouped as Europe.

Shire: United States has the largest recorded deal count among the displayed regions (9 deals). All available history
Region	Deals
United States	9
Europe	4

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Shire: 20 co-investors are shown, with Boehringer Ingelheim sharing 3 recorded deals. All available history
Co-investor	Shared deals
Boehringer Ingelheim	3
Merieux Equity Partners	3
Mitsui & Co. Global Investment	3
Takeda Ventures	3
Adams Street Partners	2
Druid BioVentures	2
Forbion	2
Genesys Capital	2
H. Lundbeck	2
Latterell Venture Partners	2
PathoCapital	2
SRIW	2
Vesalius Biocapital	2
VIVES Louvain Technology Fund	2
Abbott	1
Advent Healthcare Ventures	1
ALK Abello	1
Alto Invest	1
Apax Partners	1
ARCH Venture Partners	1